Omicron News and Research

RSS

Omicron variant of SARS-CoV-2 exhibits striking antibody evasion

Researchers discuss the likely impact on current convalescent therapies and immunity of vaccinated individuals against the SARS-CoV-2 Omicron variant.

20 Dec 2021

Reduced antibody-mediated neutralization by the SARS-CoV-2 Omicron variant

Researchers discuss the sensitivity of the SARS-CoV-2 Omicron variant towards various monoclonal antibodies.

20 Dec 2021

Researchers predict 200% increase in European coronavirus cases as Omicron spreads

New algorithms predict how the Omicron variant will spread across 27 countries in the European Union, the United Kingdom, and Switzerland.

20 Dec 2021

£28 million government funding boost to protect and vaccinate rough sleepers

Rough sleepers are being helped to get their COVID-19 vaccines and move into safe accommodation over the winter thanks to a £28 million government funding boost, the Department for Levelling Up, Housing and Communities announced today (20 December 2021).

20 Dec 2021

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

A new study highlights the potential evolutionary trade-off observed in the omicron variant, detailing the dynamics of the protein structure, its interactions, and subsequent effects.

20 Dec 2021

A test to identify antibody effectiveness against COVID-19 variants

Since the start of the COVID-19 pandemic, variants have begun to emerge. We spoke to Jacob Heggestad about his rapid test that can detect these variants.

20 Dec 2021

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

A new study shows that the Omicron variant binds to the ACE2 receptor in a significantly weaker manner than other variants and the wild-type.

20 Dec 2021

Vaccine promoters struggle to get people boosted in California’s fields

Since the start of the pandemic, Luz Gallegos and her team of 56 advocates for immigrants have battled the scorching sun, illiteracy and deadly propaganda in the fields and fruit groves of the Coachella Valley.

20 Dec 2021

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Eleven months ago, President Joe Biden assumed office during one of the most critical moments of the covid-19 pandemic. Case counts and death rates were shockingly high.

20 Dec 2021

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

A new study helps to explain the rapid spread of the Delta variant and provides the impetus to increase control measures including vaccine boosters and social distancing requirements.

20 Dec 2021

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.

19 Dec 2021

Production of functional SARS-CoV-2 spike protein in single-cell green alga

A new study uses a novel algal platform for the generation of the SARS-CoV-2 spike protein.

19 Dec 2021

More than 50% of the adult UK population boosted against COVID-19

More than 50% of the adult UK population are now boosted after the programme was accelerated this week to offer the jab to everyone aged over 18.

17 Dec 2021

Government provides record funding to support the social care sector

Care providers, residents and staff will all benefit from additional funding to support the social care sector.

17 Dec 2021

Government and faith leaders unite in the national effort to urge booster uptake

The government and faith leaders have united in the national effort to get the country boosted in the wake of a surge in Omicron cases.

17 Dec 2021

Simulating transmission dynamics of SARS-CoV-2 Omicron variant

Researchers simulated the emergence of Omicron, a novel SARS-CoV-2 VOC, in a general European setting using an individual-based transmission model.

17 Dec 2021

Predicting local surges of COVID-19 hospitalizations in 2022

Researchers have identified simple and easy-to-communicate decision rules to provide early warnings - when a pre-specified threshold of hospital capacity will likely be exceeded within a four or eight week period.

17 Dec 2021

Vaccine effectiveness against COVID-19 caused by Omicron and Delta SARS-CoV-2 variants in England

Researchers performed a test-negative case-control study to determine the effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines against the Omicron and Delta variants of SARS-CoV-2.

17 Dec 2021

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

Researchers investigated the mutations reported in the Omicron variant and its likely impact on the use of therapeutic antibodies in COVID-19 treatment as well as on vaccinated individuals.

17 Dec 2021

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

R-Biopharm announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”).

17 Dec 2021

Omicron News and Research

Omicron variant of SARS-CoV-2 exhibits striking antibody evasion

Reduced antibody-mediated neutralization by the SARS-CoV-2 Omicron variant

Researchers predict 200% increase in European coronavirus cases as Omicron spreads

£28 million government funding boost to protect and vaccinate rough sleepers

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

A test to identify antibody effectiveness against COVID-19 variants

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

Vaccine promoters struggle to get people boosted in California’s fields

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Production of functional SARS-CoV-2 spike protein in single-cell green alga

More than 50% of the adult UK population boosted against COVID-19

Government provides record funding to support the social care sector

Government and faith leaders unite in the national effort to urge booster uptake

Simulating transmission dynamics of SARS-CoV-2 Omicron variant

Predicting local surges of COVID-19 hospitalizations in 2022

Vaccine effectiveness against COVID-19 caused by Omicron and Delta SARS-CoV-2 variants in England

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News